A phase I trial of inotuzumab ozogamicin in combination with temsirolimus in patients with relapsed or refractory CD22-positive B-cell non-Hodgkin lymphomas
Article in Leukemia & Lymphoma (August 2021)
The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.
Article in Leukemia & Lymphoma (August 2021)
Article in Veterinary and Comparative Oncology (January 2018)
Article in PLOS ONE (February 2017)